MSUD: Medications for Substance and Opioid Use Disorders - 2023

4.84 (282 votes)

Recorded On: 06/28/2023

  • Register
    • Non-member - Free!
    • Regular Member - Free!
    • Retired Member - Free!
    • Affiliate Member - Free!
    • Student Member - Free!
image

Internet Explorer does not cooperate well with this platform. Please see below for options that work with APNA eLearning Center programs.*

If you have already registered for this course, please DO NOT RE-REGISTER. If you do, your completed work will be erased in the system. Instead please email MSUD@apna.org for assistance accessing your training.


The current DEA practice guidelines require Advanced Practice Registered Nurses (APRN) 
who have or are applying for Schedule III authority to complete an 8-hour MSUDMedications for Substance and Opioid Use Disorder course (8 hours of education on the treatment of persons with a substance use disorder diagnosis).

The Consolidated Appropriations Act of 2023 enacted a new one-time, eight-hour training requirement for all DEA-registered practitioners, except veterinarians, on the treatment and management of patients with opioid or other substance use disorders. For more information about the regulation visit the following links: 

Note: This course will expire 90 days from the date of registration. Please complete the course within that time frame or you may have to begin the program again. If you have questions please contact MSUD@apna.org.


Course Description: 

This course is jointly provided by American Psychiatric Nurses Association (APNA), American Academy of Addiction Psychiatry (AAAP) and Providers Clinical Support System (PCSS). The course consists of 9 individual modules. This course contains content that will help nurses who wish to offer medication for persons with a substance use disorder, including buprenorphine. Each module includes a webinar. The last course module contains an overall course evaluation, honor statement and your certificate of course completion.  This course needs to be completed within 90 days of your registration date. If you have questions, please email MSUD@apna.org

Target Audience: APRN

Learning Outcomes:
Upon completion of the course, learners will be able to:

  1. Identify patients with a substance use disorder diagnosis.
  2. Discuss the pharmacology of opioids as it relates to treatment strategies for persons with an opioid use disorder (OUD) diagnosis.
  3. Discuss medications that are appropriate for persons with a substance use disorder diagnosis.
  4. Describe the basics of office-based medications that can be used when treating special patient populations, such as adolescents, older adults, pregnancy, & psychiatric comorbidities with a substance use disorder diagnosis.
  5. Discuss approved antagonist, partial agonist, and agonist medications to treat OUD.
  6. Discuss various laboratory tests used when assessing for a substance use disorder diagnosis.
  7. Discuss ways to mitigate the risk of opioid use in pain management.   
  8. Utilize evidence-based resources to ensure providers have the confidence to prescribe medication for patients with substance use disorder diagnosis. 

Pricing: Free

Keywords: MSUD Training, Addictions, MOUD, Substance Use Disorders, Opioid Use Disorder

Register:  

The course is free of charge and can be accessed by clicking the Register button above. You will be prompted to login with your APNA account. If you do not have an APNA account, select the button, "create an account" and complete the listed information to create a free non-member profile. 

Disclosures:

The APNA nurse planner and members of the APNA, AAAP and PCSS planning committee have no financial relationships or conflict of interest to disclose.  This educational activity may contain discussion of off-label usage of drugs that are not indicated by the FDA. The American Psychiatric Nurses Association (APNA) and the American Academy of Addiction Psychiatry (AAAP) do not recommend usage of any agent outside the FDA approved/labeled indications.

Release Date: August 31, 2023
Access to the 2023 course will end: August 31, 2026

Nursing Continuing Professional Development: 
8.0 pharmacology contact hours. *In order to receive contact hours for the program, participants must: complete all the components of the course, complete the overall course evaluation, and the honor statement.  Your nursing continuing professional development (NCPD) certificate will be generated online and available for immediate printing. Credit cannot be earned unless all components of the program are completed. No partial credit can be awarded.

The American Psychiatric Nurses Association is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Accreditation of this nursing continuing professional development educational activity does not imply endorsement by APNA or ANCC of any commercial products discussed in the context of this activity. 

Funding Statement:  
Funding for this initiative was made possible by cooperative agreement no. 1H79TI086770 and grant no. 1H79TI085588 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

*For an uninterrupted learning experience, please download and use Google ChromeMozilla FirefoxMicrosoft EdgeSafari, etc. If you continue to experience issues, you may need to update your browser.


Components visible upon registration.